Role of ΔNp63γ in Epithelial to Mesenchymal Transition*

Although members of the p63 family of transcription factors are known for their role in the development and differentiation of epithelial surfaces, their function in cancer is less clear. Here, we show that depletion of the ΔNp63α and β isoforms, leaving only ΔNp63γ, results in epithelial to mesenchymal transition (EMT) in the normal breast cell line MCF10A. EMT can be rescued by the expression of the ΔNp63α isoform. We also show that ΔNp63γ expressed in a background where all the other ΔNp63 are knocked down causes EMT with an increase in TGFβ-1, -2, and -3 and downstream effectors Smads2/3/4. In addition, a p63 binding site in intron 1 of TGFβ was identified. Inhibition of the TGFβ response with a specific inhibitor results in reversion of EMT in ΔNp63α- and β-depleted cells. In summary, we show that p63 is involved in inhibiting EMT and reduction of certain p63 isoforms may be important in the development of epithelial cancers.

[1]  D. Nguyen,et al.  Acetylation regulates the differentiation‐specific functions of the retinoblastoma protein , 2004, The EMBO journal.

[2]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[3]  T. Jacks,et al.  p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair , 2009, PLoS genetics.

[4]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[5]  R. Nenutil,et al.  Differential expression of p63 isoforms in normal tissues and neoplastic cells , 2002, The Journal of pathology.

[6]  D. Patel,et al.  Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6 , 2006, Oncogene.

[7]  P. Johnston,et al.  CD44 Potentiates the Adherence of Metastatic Prostate and Breast Cancer Cells to Bone Marrow Endothelial Cells , 2004, Cancer Research.

[8]  S. McDade,et al.  The role of p63 in epidermal morphogenesis and neoplasia. , 2010, Biochemical Society transactions.

[9]  R. Mantovani,et al.  Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains† , 2002, Molecular and Cellular Biology.

[10]  A. Yang,et al.  A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism , 2002, Molecular and Cellular Biology.

[11]  Shridar Ganesan,et al.  X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.

[12]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[13]  S. Chi,et al.  Frequent alteration of p63 expression in human primary bladder carcinomas. , 2000, Cancer research.

[14]  C. Missero,et al.  p63 Suppresses Non-epidermal Lineage Markers in a Bone Morphogenetic Protein-dependent Manner via Repression of Smad7* , 2009, The Journal of Biological Chemistry.

[15]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[16]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[17]  D. McCance,et al.  Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. , 2006, Cancer research.

[18]  T. Crook,et al.  High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? , 2000, Oncogene.

[19]  Jason S. Carroll,et al.  p63 regulates an adhesion programme and cell survival in epithelial cells , 2006, Nature Cell Biology.

[20]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[21]  P. Delvenne,et al.  Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. , 2010, The American journal of pathology.

[22]  H. Kato,et al.  Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Δ Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51 , 2001, British Journal of Cancer.

[23]  Antonio Rosato,et al.  A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis , 2009, Cell.

[24]  Michael K. Wendt,et al.  Mechanisms of the epithelial-mesenchymal transition by TGF-beta. , 2009, Future oncology.

[25]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[26]  Christopher P Crum,et al.  p63 in epithelial survival, germ cell surveillance, and neoplasia. , 2010, Annual review of pathology.

[27]  Guojun Wu,et al.  ΔNp63α Up-Regulates the Hsp70 Gene in Human Cancer , 2005, Cancer Research.

[28]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[29]  Y. Mitani,et al.  ΔNp63α‐dependent expression of Id‐3 distinctively suppresses the invasiveness of human squamous cell carcinoma , 2009, International journal of cancer.

[30]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[31]  C. Cordon-Cardo,et al.  Loss of p63 expression is associated with tumor progression in bladder cancer. , 2002, The American journal of pathology.

[32]  J. Shay,et al.  Immortalization of human mammary epithelial cells by SV40 large T-antigen involves a two step mechanism , 1993, In Vitro Cellular & Developmental Biology - Animal.

[33]  Misako Sato,et al.  P63 expression in normal, hyperplastic and malignant breast tissues , 2002, Breast cancer.

[34]  R. Knight,et al.  p63 in epithelial development , 2008, Cellular and Molecular Life Sciences.

[35]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.